SCHEMBL1471263

SCHEMBL1471263

CCSCSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14312154 0.93
SCHEMBL4343300 0.79
SCHEMBL1937162 0.79
SCHEMBL9229050 0.75
SCHEMBL22420335 0.72
Diethyl Sulfide SCHEMBL7714992 0.70
SCHEMBL1187 0.69
SCHEMBL570237 0.69
Diethyl Sulfide SCHEMBL11391850 0.69
Diethyl Sulfide SCHEMBL1327 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119058235-A Fluid ejection head, method for manufacturing fluid ejection head, fluid ejection assembly, and fluid ejection device 株式会社理光 2024-12-03 CN disclosed
CN-115003709-A Compound, method for producing compound, and curable composition 株式会社艾迪科 2022-09-02 CN disclosed
EP-3317301-B1 COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3 NOVARTIS AG (CH) 2021-04-07 EP disclosed
WO-2020196819-A1 CURABLE RESIN COMPOSITION 株式会社ADEKA 2020-10-01 WO disclosed
US-20170204225-A1 POLYMERIZATION PROCESS OF POLYARYLENE SULFIDE INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-07-20 US disclosed
US-20170198098-A1 POLYMER INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) 2017-07-13 US disclosed
EP-2046714-B1 Cyclopentane derivatives as antiglaucoma agents ALLERGAN INC (US) 2015-12-09 EP disclosed
CN-102666676-B Film and uses thereof MITSUI CHEMICALS, INC. (JP) 2015-11-25 CN disclosed
CN-103429369-B Method for producing composite nickel nanoparticles NIPPON STEEL CHEMICAL CO 2015-06-24 CN disclosed
CN-102977309-B Polymerizable composition for polythiourethane optical material, polythiourethane optical material obtained from the polymerizable composition, and polymerization catalyst for polythiourethane optical material MITSU CHEMICALS INC 2015-04-15 CN disclosed
US-20070219265-A1 SUBSTITUTED GAMMA LACTAMS AS THERAPEUTIC AGENTS ALLERGAN, INC. 2007-09-20 US disclosed
WO-2007064664-A2 PROSTAGLANDIN EP4 AGONISTS FOR THE TREATMENT OF GASTRIC CONDITIONS ALLERGAN, INC. (US) 2007-06-07 WO disclosed
US-20070123568-A1 Therapeutic methods using prostaglandin EP4 agonist components ALLERGAN, INC. (US) 2007-05-31 US disclosed
US-20070123569-A1 THERAPEUTIC METHODS USING PROSTAGLANDIN EP4 AGONIST COMPONENTS ALLERGAN, INC. (US) 2007-05-31 US disclosed
US-20070112051-A1 CYCLOPENTANE HEPTAN(ENE)OIC ACID, 2-HETEROARYLALKENYL DERIVATIVES AS THERAPEUTIC AGENTS ALLERGAN, INC. 2007-05-17 US disclosed
EP-1057808-B1 Sulfur-containing unsaturated carboxylate compound and its use MITSUI CHEMICALS INC (JP) 2007-03-14 EP disclosed
US-20070054893-A1 Prostaglandin analogs ALLERGAN, INC. 2007-03-08 US disclosed
US-7179820-B2 Piperidinyl prostaglandin E analogs ALLERGAN, INC. (US) 2007-02-20 US disclosed
US-7169807-B2 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists ALLERGAN, INC. (US) 2007-01-30 US disclosed
US-20070010495-A1 10-HYDROXY-11-DIHYDROPROSTAGLANDIN ANALOGS AS SELECTIVE EP4 AGONISTS ALLERGAN, INC. (US) 2007-01-11 US disclosed